•
Jun 30, 2019

Voyager Therapeutics Q2 2019 Earnings Report

Total Revenue
$46.1M
Previous year: $2.58M
+1689.8%
EPS
$0.29
Previous year: -$0.8
-136.3%
Gross Profit
$20.8M
Previous year: -$13.9M
-249.1%
Cash and Equivalents
$79.9M
Previous year: $59.6M
+34.0%
Free Cash Flow
-$33.6M
Previous year: -$23.8M
+41.1%
Total Assets
$389M
Previous year: $215M
+81.0%

Voyager Therapeutics

Voyager Therapeutics